Vista simple de metadatos

dc.contributorBMJ Publishing Groupes_CL
dc.contributor.authorAlliende, C. [s.af]es_CL
dc.contributor.authorKwon, Y-J. [s.af]es_CL
dc.contributor.authorBrito, M. [s.af]es_CL
dc.contributor.authorMolina, C. [Chile. Universidad Mayor]es_CL
dc.contributor.authorAguilera, S. [Chile. Universidad Andrés Bello]es_CL
dc.contributor.authorPérez, P. [s.af]es_CL
dc.contributor.authorLeyton, L. [Chile. Universidad de Chile. Facultad de Medicina]es_CL
dc.contributor.authorQuest, A. [Chile. Universidad de Chile. Facultad de Medicina]es_CL
dc.contributor.authorMandel, U. [Dinamarca. University of Copenhagen]es_CL
dc.contributor.authorVeerman, E. [Holanda. University of Amsterdam]es_CL
dc.date.accessioned2018-09-07T13:04:09Z
dc.date.available2018-09-07T13:04:09Z
dc.date.issued2008es_CL
dc.identifier.citationAlliende C, Kwon YJ, Brito M, Molina C, Aguilera S, Pérez P, Leyton L, Quest AF, Mandel U, Veerman E, Espinosa M, Clausen H, Leyton C, Romo R, González MJ. Reduced sulfation of muc5b is linked to xerostomia in patients with Sjögren syndrome. Ann Rheum Dis. 2008 Oct;67(10):1480-7. Epub 2007 Nov 12. PubMed PMID: 17998215.es_CL
dc.identifier.issnISSN 0003-4967es_CL
dc.identifier.issnESSN 1468-2060es_CL
dc.identifier.urihttps://ard.bmj.com/content/67/10/1480.long#es_CL
dc.identifier.urihttp://dx.doi.org/10.1136/ard.2007.078246es_CL
dc.identifier.urihttp://repositorio.umayor.cl/xmlui/handle/sibum/2613
dc.description.abstractObjectives: MUC5B contains sulfated and sialylated oligosaccharides that sequester water required for moisturising the oral mucosa. Xerostomia, in patients with Sjogren syndrome, is generally associated with reduced quantities, rather than altered properties, of saliva. Here, we determined the amount of MUC5B (mRNA and protein) as well as sulfation levels in salivary glands of patients with normal or altered unstimulated salivary flow. Localisation of MUC5B and ulfated MUC5B, as well as total levels sulfated groups were determined and compared with acini basal lamina disorganisation. Patients and methods: In all, 18 patients with normal or altered unstimulated salivary flow and 16 controls were studied. MUC5B mRNA and protein were evaluated in salivary glands by semiquantitative RT-PCR and Western blot analysis. MUC5B sulfation was determined by Western blotting. MUC5B and sulfo-Lewis(a) antigen localisation were assessed by immunohistochemistry. The total amount of sulfated oligosaccharides was determined microdensitometrically. Results: No significant differences were detected in MUC5B mRNA and protein levels between controls and patients, while sulfo-Lewis(a) antigen levels were lower in patients. The number of sulfo-Lewis(a) positive mucous acini was reduced in patients but no correlation was observed between lower levels of sulfation and unstimulated salivary flow. Microdensitometric data confirmed the presence of reduced sulfated oligosaccharides levels in mucous acini from patients with highly disorganised basal lamina. Conclusion: Disorganisation of the basal lamina observed in patients with Sjogren syndrome may lead to dedifferentiation of acinar mucous cells and, as a consequence, alter sulfation of MUC5B. These changes are suggested to represent a novel mechanism that may explain xerostomia in these patientses_CL
dc.description.sponsorshipEste trabajo fue financiado por grants (to M-JG, SA, CM) de FONDECYT-CHILE 1020755, 1050192. PP and MB fueron financiados por PhD fellowships granted Conicyt, Mecesup-Postgrado Universidad de Chile 99-03 y Laboratorio Tecno-Farma-Chile. LL fue financiado por FONDECYT-CHILE 1040390, AFGQ y FONDAP 15010006es_CL
dc.format.extentARTÍCULO ORIGINALes_CL
dc.language.isoenes_CL
dc.publisherCIENCIASes_CL
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chilees_CL
dc.subjectREUMATOLOGÍAes_CL
dc.titleReduced sulfation of muc5b is linked to xerostomia in patients with Sjogren syndromees_CL
dc.typeArtículo o Paperes_CL
umayor.indizadorCOTes_CL
umayor.politicas.sherpa/romeoLicencia color: VERDE C/R (Se puede archivar el pre-print y el post-print o versión de editor/PDF, el autor no puede archivar la versión del editor/PDF)--Postprint: el autor puede archivar la versión post-print (ie la versión final posterior a la revisión por pares), Versión de editor/PDF: cross el autor no puede archivar la versión del editor/PDF. Condiciones generales: On author's personal website, institutional website or institutional repository immediately upon online publication, Deben reconocerse el copyright y la fuente editorial, Debe ir enlazado a la versión de editor, La versión de editor/PDF no puede utilizarse, Los autores conservan el copyright, If funding agency rules apply, authors may post articles in PubMed Central and mirror sites, website, institutional website or institutional repository, On PubMed Central after 12 months embargo from print publication, or as required by funding agency, On social networks such as ResearchGate and Mendeley after 6 months embargo from print publication// Disponible en: http://www.sherpa.ac.uk/romeo/issn/0003-4967/es/es_CL
umayor.indexadoWOSes_CL
dc.identifier.doi10.1136/ard.2007.078246es_CL]
umayor.indicadores.wos-(cuartil)Q1es_CL
umayor.indicadores.scopus-(scimago-sjr)sin informaciónes_CL


Vista simple de metadatos



Modificado por: Sistema de Bibliotecas Universidad Mayor - SIBUM
DSpace software copyright © 2002-2018  DuraSpace